Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Divozilimab (Anti-CD20) For research use only.
Not for use in humans.

Divozilimab (Anti-CD20)

Synonyms: BCD-132

Divozilimab (BCD-132) is a humanised monoclonal antibody against CD20 (CD20) with the potential to be used in multiple sclerosis research. MW : 145.26 KD.

Divozilimab (Anti-CD20)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Divozilimab (BCD-132) is a humanised monoclonal antibody against CD20 (CD20) with the potential to be used in multiple sclerosis research. MW : 145.26 KD.

Product Details

CAS No. 2254061-60-2
Molecular Weight 145.26
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Divozilimab (Anti-CD20) | Divozilimab (Anti-CD20) supplier | purchase Divozilimab (Anti-CD20) | Divozilimab (Anti-CD20) cost | Divozilimab (Anti-CD20) manufacturer | order Divozilimab (Anti-CD20) | Divozilimab (Anti-CD20) distributor